 NEW YORK, Aug. 6, 2021 PRNewswire -- AIkido Pharma Inc. Nasdaq: AIKI AIkido or the Company today provided and update on the use of Machine Learning in support of its antiviral platform with the University of Maryland Baltimore School of Medicine. The Company stated: The goal for the project is the identification and optimization of anti-viral compounds that inhibit viral replication by targeting a protein complex that degrades RNA at the cellular level. 